Your browser doesn't support javascript.
loading
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.
Spyridonidis, Alexandros; Labopin, Myriam; Savani, Bipin N; Niittyvuopio, Riitta; Blaise, Didier; Craddock, Charles; Socié, Gerard; Platzbecker, Uwe; Beelen, Dietrich; Milpied, Noel; Cornelissen, Jan J; Ganser, Arnold; Huynh, Anne; Griskevicius, Laimonas; Giebel, Sebastian; Aljurf, Mahmoud; Brissot, Eolia; Malard, Florent; Esteve, Jordi; Peric, Zinaida; Baron, Frédéric; Ruggeri, Annalisa; Schmid, Christoph; Gilleece, Maria; Gorin, Norbert-Claude; Lanza, Francesco; Shouval, Roni; Versluis, Jurjen; Bug, Gesine; Fløisand, Yngvar; Ciceri, Fabio; Sanz, Jamie; Bazarbachi, Ali; Nagler, Arnon; Mohty, Mohamad.
Affiliation
  • Spyridonidis A; Department of Internal Medicine, Bone Marrow Transplantation Unit, University Hospital of Patras, Patras, Greece. spyridonidis@upatras.gr.
  • Labopin M; Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
  • Savani BN; Long term Transplant Clinic, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Niittyvuopio R; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
  • Blaise D; Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
  • Craddock C; University Hospital Birmingham NHS Trust, Birmingham, UK.
  • Socié G; Department of Hematology-BMT, Hospital St. Louis, Paris, France.
  • Platzbecker U; Hematology and Cellular Therapy, University Hospital, Leipzig, Germany.
  • Beelen D; Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany.
  • Milpied N; CHU Bordeaux, Hospital Haut-Leveque, Pessac, France.
  • Cornelissen JJ; Erasmus MC Cancer Institute, Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Huynh A; CHU - Institut Universitaire du Cancer Toulouse, Oncopole, I.U.C.T-O, Toulouse, France.
  • Griskevicius L; Hematology, Oncology & Transfusion Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
  • Giebel S; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cencer Center and Institute of Oncology, Gliwice, Poland.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Brissot E; Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
  • Malard F; Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
  • Esteve J; Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain.
  • Peric Z; Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia.
  • Baron F; GIGA-I3 Hematology, University and CHU of Liège, Liège, Belgium.
  • Ruggeri A; Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Roma, Italy.
  • Schmid C; Department of Hematology and Oncology, Universitäts-Klinikum Augsburg, Augsburg, Germany.
  • Gilleece M; Leeds Teaching Hospitals Trust, Leeds, UK.
  • Gorin NC; Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
  • Lanza F; Hematology and Romagna Metropolitan Transplant Network, Hospital of Ravenna, Ravenna, Italy.
  • Shouval R; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Versluis J; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Bug G; Department of Medicine 2, Hematology and Oncology, University Hospital, Goethe University, Frankfurt, Germany.
  • Fløisand Y; Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Ciceri F; Hematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Sanz J; Hematology Department, University Hospital La Fe, Valencia, Spain.
  • Bazarbachi A; Bone Marrow Transplantation Program, American University of Beirut, Medical Center, Beirut, Lebanon.
  • Nagler A; Hematology Division, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Mohty M; Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Bone Marrow Transplant ; 55(6): 1114-1125, 2020 06.
Article in En | MEDLINE | ID: mdl-31996792
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2020 Document type: Article Affiliation country: Grecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2020 Document type: Article Affiliation country: Grecia Country of publication: Reino Unido